Development and Application of a Dynamic Three-dimensional Quantitative Facial Measurement Device

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05981651
Collaborator
(none)
200
1
30
6.7

Study Details

Study Description

Brief Summary

The aim of this project is to successfully develop and industrialise the "Facial Movement 3D Dynamic Quantitative Measurement Device", which is a commercial device that can provide dynamic indicators of facial movement, and can practically solve the evaluation problems of facial paralysis for doctors and patients, and has important clinical value and social benefits.

Condition or Disease Intervention/Treatment Phase
  • Other: non-intervention

Detailed Description

Based on the current optimal high-precision face key point technology, the effective high-precision automatic face recognition model conforming to the Asian face is established through specialised training with targeted marker data, time series training optimisation based on optical flow, and local image tracking technology. The 3D reconstruction technique is then used to reconstruct the 3D spatial coordinates of the face keypoints, so as to realise the multi-camera 3D tracking of the face keypoints. The displacement of the key points is used to respond to the facial muscle activity characteristics of facial paralysis patients.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Development and Application of a Dynamic Three-dimensional Quantitative Facial Measurement Device
Actual Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Dec 30, 2024
Anticipated Study Completion Date :
Dec 30, 2024

Arms and Interventions

Arm Intervention/Treatment
training session

A total of 150 facial expression videos of healthy volunteers and facial palsy patients were collected as a training set for the algorithm

Other: non-intervention
non-intervention

test set

A total of 50 cases of healthy volunteers and patients with facial palsy were used as the test set for the algorithm

Other: non-intervention
non-intervention

Outcome Measures

Primary Outcome Measures

  1. Facial feature point displacement distance [3 months]

    Displacement of corresponding facial feature points when volunteers perform specific actions such as specific expressions (raising eyebrow, closing eyes, shrugging nose, smiling and whistling)

  2. Facial Feature Point Velocity [3 months]

    Velocity of the corresponding facial feature points of volunteers when accomplishing specific actions such as specific expressions (raising eyebrows, closing eyes, shrugging nose, smiling, whistling)

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Older than 14 years

  2. No history of facial surgery, facial trauma, or scars obscuring the facial features.

  3. Able to perform relevant actions according to instructions

  4. Willingness to participate in the study

Exclusion Criteria:
  1. Unwillingness to participate in the study

  2. Unable to co-operate with relevant command actions

  3. Obvious trauma, scars, etc. obscuring the facial features

  4. Less than 14 years of age

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking Union Medical College Hospital Beijing Beijing China 100730

Sponsors and Collaborators

  • Peking Union Medical College Hospital

Investigators

  • Principal Investigator: Guodong Feng, Peking Union Medical College Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Guodong Feng, chief physician, Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT05981651
Other Study ID Numbers:
  • PekingUMCH record I-22PJ1121
First Posted:
Aug 8, 2023
Last Update Posted:
Aug 8, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 8, 2023